Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...

In a flurry of executive orders signed just hours after he took office, President Donald Trump rescinded a Biden administration order on prescription drugs.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.